Lazcluze Shows Central Nervous System Activity In EGFR-Variant NSCLC
Lazcluze shows promise as a potential treatment option for patients with EGFR-variant NSCLC, demonstrating significant central nervous system activity in ...
Tag: Lazcluze
First-Line Rybrevant Plus Lazcluze Shows Trend Toward Overall Survival in EGFR-Positive NSCLC
First-Line Rybrevant Plus Lazcluze Shows Trend Toward Overall Survival in EGFR-Positive NSCLCIn the first line of treatment, Rybrevant (amivantamab) plus ...